| Dr Alexandria Victoria White, DPT | |
|
183 Main St Ste D, Trussville, AL 35173-1496 | |
| (205) 655-1009 | |
| Not Available |
| Full Name | Dr Alexandria Victoria White |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 183 Main St Ste D, Trussville, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952179996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PTH11611 (Alabama) | Primary |
| Entity Name | Ew Motion Therapy Trussville Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063735223 PECOS PAC ID: 2860523552 Enrollment ID: O20100624000210 |
News Archive
Betting that thin is in — and might be the only way forward — Senate Republicans are eyeing a "skinny repeal" that rolls back an unpopular portion of the federal health law. But experts warn that the idea has been tried before, and with little success.
The failure to provide treatment has led to crowded emergency rooms and jails and thousands of untreated people living on the streets, the newspaper reports.
The Center for Global Health Policy's "Science Speaks" blog summarizes an event held Thursday, titled "AIDS-free Generation? Not Without Women," that was sponsored by the National Council of Women's Organizations. The session aimed "to draw attention to pivotal issues surrounding the impact of AIDS on women worldwide" ahead of the International AIDS Conference, the blog states.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx's oncology drug candidate tamibarotene.
A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandria Victoria White, DPT 4 Office Park Cir Ste 217, Mountain Brk, AL 35223-2674 Ph: (205) 263-2770 | Dr Alexandria Victoria White, DPT 183 Main St Ste D, Trussville, AL 35173-1496 Ph: (205) 655-1009 |
News Archive
Betting that thin is in — and might be the only way forward — Senate Republicans are eyeing a "skinny repeal" that rolls back an unpopular portion of the federal health law. But experts warn that the idea has been tried before, and with little success.
The failure to provide treatment has led to crowded emergency rooms and jails and thousands of untreated people living on the streets, the newspaper reports.
The Center for Global Health Policy's "Science Speaks" blog summarizes an event held Thursday, titled "AIDS-free Generation? Not Without Women," that was sponsored by the National Council of Women's Organizations. The session aimed "to draw attention to pivotal issues surrounding the impact of AIDS on women worldwide" ahead of the International AIDS Conference, the blog states.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx's oncology drug candidate tamibarotene.
A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.
› Verified 6 days ago